All Access Articles |
- Biocryst Appoints Babar Ghias as CFO | 2025-07-07 | BIOTECHNOLOGY
- Biocryst Pharmaceuticals Sells European Orladeyo Business for Up to $264M | 2025-06-27 | BIOTECHNOLOGY
- FDA Accepts Biocryst's NDA for Pediatric HAE Drug | 2025-05-14 | BIOTECHNOLOGY
- BioCryst Pharmaceuticals Reports Strong Revenue Growth | 2024-02-26 | BIOTECHNOLOGY